Effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis
We investigated the effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis for 3 and 5 years. Significant improvement found the decrease of the frequency of clinical exacerbations and delay the accumulation of physical disability during treatment period.
Saved in:
| Main Authors: | V. M. Alifirova, M. A. Titova, A. A. Vereschaka |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Siberian State Medical University (Tomsk)
2010-08-01
|
| Series: | Бюллетень сибирской медицины |
| Subjects: | |
| Online Access: | https://bulletin.ssmu.ru/jour/article/view/1618 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Experience with the long-term use of interferons β in the treatment of relapsing-remitting multiple sclerosis. Case report
by: Taras O. Simaniv, et al.
Published: (2024-12-01) -
Amygdala volume changes as a potential marker of multiple sclerosis progression: links to EDSS scores and PIRA
by: Aleksandra Pogoda-Wesołowska, et al.
Published: (2025-08-01) -
Relationship between kappa light chain level and demyelinating lesion localization in secondary progressive multiple sclerosis
by: İbrahim Acır, et al.
Published: (2025-12-01) -
Volumetric assessment of hypothalamus in relapsing–remitting multiple sclerosis
by: Sara Sameh AbdelRahman Abdallah, et al.
Published: (2025-07-01) -
The condition of the cardiovascular system in patients with relapsing-remitting multiple sclerosis
by: O. A. Traktirskaya, et al.
Published: (2019-03-01)